A detailed history of Yousif Capital Management, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Yousif Capital Management, LLC holds 21,258 shares of GKOS stock, worth $3.39 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
21,258
Previous 21,604 1.6%
Holding current value
$3.39 Million
Previous $2.81 Million 13.26%
% of portfolio
0.04%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

SELL
$126.42 - $152.67 $43,741 - $52,823
-346 Reduced 1.6%
21,258 $3.19 Million
Q3 2024

Oct 30, 2024

BUY
$113.62 - $135.39 $128,163 - $152,719
1,128 Added 5.51%
21,604 $2.81 Million
Q2 2024

Jul 31, 2024

SELL
$89.48 - $118.35 $159,095 - $210,426
-1,778 Reduced 7.99%
20,476 $2.42 Million
Q1 2024

Apr 26, 2024

SELL
$76.4 - $96.33 $190,618 - $240,343
-2,495 Reduced 10.08%
22,254 $2.1 Million
Q4 2023

Feb 01, 2024

BUY
$59.53 - $85.11 $27,681 - $39,576
465 Added 1.91%
24,749 $1.97 Million
Q3 2023

Oct 30, 2023

SELL
$69.23 - $79.09 $93,322 - $106,613
-1,348 Reduced 5.26%
24,284 $1.83 Million
Q2 2023

Aug 02, 2023

SELL
$45.44 - $71.21 $57,208 - $89,653
-1,259 Reduced 4.68%
25,632 $1.83 Million
Q1 2023

May 02, 2023

SELL
$43.88 - $52.48 $153,799 - $183,942
-3,505 Reduced 11.53%
26,891 $1.35 Million
Q4 2022

Jan 09, 2023

SELL
$40.82 - $57.75 $333,499 - $471,817
-8,170 Reduced 21.18%
30,396 $0
Q3 2022

Nov 04, 2022

SELL
$46.84 - $58.49 $13,396 - $16,728
-286 Reduced 0.74%
38,566 $2.05 Million
Q2 2022

Aug 01, 2022

SELL
$34.86 - $63.77 $130,376 - $238,499
-3,740 Reduced 8.78%
38,852 $1.77 Million
Q1 2022

May 12, 2022

BUY
$44.33 - $57.82 $26,376 - $34,402
595 Added 1.42%
42,592 $2.46 Million
Q4 2021

Jan 31, 2022

BUY
$40.27 - $56.99 $1.69 Million - $2.39 Million
41,997 New
41,997 $1.87 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.6B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.